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2896Objective: The choice of cerebral perfusion strategy for aortic arch surgery has been debated, and the superi-
ority of antegrade (ACP) or retrograde (RCP) cerebral perfusion has not been shown.We examined the early and
late outcomes for ACP versus RCP in proximal (hemi-) arch replacement using deep hypothermic circulatory
arrest (DHCA).
Methods: A retrospective analysis of a prospectively maintained database was performed for all patients under-
going elective and nonelective hemiarch replacement at a single referral institution from June 2005 to February
2013. Total arch cases were excluded to limit the analysis to shorter DHCA times and a more uniform patient
population for whom clinical equipoise regarding ACP versus RCP exists. A total of 440 procedures were iden-
tified, with 360 (82%) using ACP and 80 (18%) using RCP. The endpoints included 30-day/in-hospital and late
outcomes. A propensity score with 1:1 matching of 40 pre- and intraoperative variables was used to adjust for
differences between the 2 groups.
Results:All 80 RCP patients were propensity matched to a cohort of 80 similar ACP patients. The pre- and intra-
operative characteristics were not significantly different between the 2 groups after matching. No differences
were found in 30-day/in-hospital mortality or morbidity outcomes. The only significant difference between
the 2 groups was a shorter mean operative time in the RCP cohort (P ¼ .01). No significant differences were
noted in late survival (P ¼ .90).
Conclusions: In proximal arch operations using DHCA, equivalent early and late outcomes can be achieved
with RCP and ACP, although the mean operative time is significantly less with RCP, likely owing to avoidance
of axillary cannulation. Questions remain regarding comparative outcomes with straight DHCA and lesser de-
grees of hypothermia. (J Thorac Cardiovasc Surg 2014;148:2896-902)See related commentary on pages 2902-4.Aortic arch surgery represents a technically demanding and
high-risk cardiovascular operation. Given the mandatory
period of cerebral ischemia inherent in the operation, subse-
quent neurologic dysfunction has been a concern. The
reported incidence of adverse neurologic events after aortic
arch surgery has ranged from 3% to 16%.1 Consequently,
attention has been focused on optimization of neuroprotec-
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The Journal of Thoracic and Cardiovascular Surhypothermic circulatory arrest (DHCA), has been used to
minimize cerebral metabolic demand and protect cerebral
tissue from ischemia and provide adequate neurologic pro-
tection during arch surgery.2-5 Although DHCA alone
has been shown to be safe, most centers have used some
form of adjunctive cerebral perfusion to minimize
neurologic morbidity, particularly in cases requiring
longer circulatory arrest times. The most common
perfusion methods have been antegrade (ACP) and/or
retrograde (RCP) cerebral perfusion, both popularized in
the early 1990s.6,7 Both strategies have demonstrated
adequate prevention of permanent neurologic dysfunction,
although some studies have revealed an increased rate of
transient neurologic dysfunction (TND) with RCP.5,8
However, the existing data have consisted primarily of
voluminous observational studies without adequate control
groups to provide robust clinical evidence.9 To date, a com-
parison of the 2 strategies head to head in a uniform patient
population has not been conducted to truly determine
whether either technique provides superior short- and
long-term outcomes. Thus, the aim of the present
study was to determine the comparative effectiveness of
ACP versus RCP in the setting of DHCA in patientsgery c December 2014
Abbreviations and Acronyms
ACP ¼ antegrade cerebral perfusion
CPB ¼ cardiopulmonary bypass
DHCA ¼ deep hypothermic circulatory arrest
LOS ¼ length of stay
RCP ¼ retrograde cerebral perfusion
TND ¼ transient neurologic dysfunction
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replacement.
METHODS
Patients and Data Source
All patients undergoing elective and nonelective hemiarch replacement
from June 2005 to February 2013 were identified using a prospectively
maintained database at a single tertiary referral institution. All cases of total
arch replacement were excluded to limit the analysis to shorter DHCA
times and a more homogenous patient population for which clinical equi-
poise between ACP and RCP exists.10 All pre-, intra-, and postoperative
variables were obtained from the Duke Thoracic Aortic Surgery Database,
a prospectively maintained clinical registry of all patients undergoing
thoracic aortic surgery at Duke University Medical Center (Durham,
NC). After review and approval by the institutional review board of
Duke University, the need for individual patient consent was waived.
The query of the database identified 440 hemiarch replacements performed
from June 2005 to February 2013. Of the 440 patients, 360 had undergone
hemiarch replacement with ACP and 80 with RCP. The Society of Thoracic
Surgeons definitionswere used to define the patient comorbidities and post-
operative outcomes.11 All patients received lifelong postoperative follow-
up examinations at the Duke University Center for Aortic Disease. The
Social Security Death Index (available at: http://ssdi.rootsweb.com/) was
queried to confirm all deaths and survey patients lost to follow-up.
Conduct of Procedures
All patients included in the present study had undergonemedian sternot-
omy and replacement of the aortic root or supracoronary ascending
aorta (with or without the aortic valve) with concomitant hemiarch re-
placement using DHCA, as previously described.12,13 Neurophysiologic
intraoperative monitoring with electroencephalography was used to
guide the degree of cooling in all elective operations and when available
for the nonelective operations. A total of 358 cases (81.4%) were
monitored, as previously described.14,15 In brief, the patients were cooled
until electrocerebral inactivity was reached, after which, DHCA was
begun. Electrocerebral inactivity ensures maximal metabolic suppression
of the brain and, therefore, maximal neurocerebral protection.15
Adjunctive cerebral perfusion began after opening of the aortic arch.
ACP was the preferred adjunctive strategy early in the series, with RCP
reserved for cases in which the right axillary artery was not suitable for can-
nulation owing to a small diameter or dissection of the vessel, as previously
described.12 However, later in the series, RCP became increasingly used
owing to the comfort of the team with the technique, especially in nondis-
section cases, and the perceived clinical equipoise regarding the outcomes
compared with ACP (Figure 1).
For theACP cases, the right axillary arterywas cannulatedwith an 8-mm
Dacron side graft, and ACP was performed with the base of the innominate
and left common carotid arteries clamped and perfusion by way of the right
axillary graft at a flow rate of 5 to 15 mL/kg/min and an inflow temperature
of 12C to a target right radial arterial line pressure of 50 to 70 mmHg. For
theRCPcases, a right-angled, long 26F superior vena cava cannulawas usedThe Journal of Thoracic and Carwith an average flow rate of 150 to 450 mL/min at 12C retrograde by way
of the snared superior vena cava cannula to a target central venous
pressure of 25mmHg. For theRCPcases, initial arterial cannulation for car-
diopulmonary bypass (CPB) was most commonly by way of the distal
ascending aorta, although the left axillary artery or femoral artery were
occasionally used if necessitated by patient pathologic features or anatomy.
In all cases, after completion of the hemiarch anastomosis, full flow CPB
was reinstituted and the patient rewarmed after a 5-minute period of cold
reperfusion for free radical washout.
Outcomes
The primary endpoint of the study was any neurologic complication,
defined as any TND, transient ischemic attack, or clinical stroke. Clinical
stroke was defined using The Society of Thoracic Surgeons definition as
a new neurologic deficit persisting for24 hours. The secondary endpoints
included 30-day/in-hospital mortality, composite 30-day/in-hospital major
morbidity, operative time, the usual perioperative outcomes, and long-term
survival. Composite 30-day/in-hospital major morbidity was defined using
the standard Society of Thoracic Surgeons definition, including any reop-
eration, prolonged (>24 hours) mechanical ventilation, acute renal failure
(maximum postoperative creatinine 23 the baseline creatinine and>2.0 g/
dL), new onset dialysis, or clinical stroke.
Statistical Analysis
All comparisons were made between the ACP and RCP groups on an
intention to treat basis according to the cerebral perfusion strategy used.
To create groups with a similar propensity to receive either ACP or RCP,
a propensity score-matched analysis was conducted. Propensity scores
for receiving ACP or RCP were calculated with the following characteris-
tics: age, gender, race, patient comorbidities, New York Heart Association
class, ejection fraction, presence of preoperative shock or malperfusion,
previous aortic surgery, concomitant cardiac surgical procedures, proce-
dural status, redo sternotomy, type of aortic procedure performed, proce-
dural indication, preoperative rupture or cardiac tamponade, American
Society of Anesthesiologists class, maximal aortic diameter, minimum
nasopharyngeal temperature, circulatory arrest, CPB and crossclamp
times, and use of electroencephalographic monitoring. The patients were
matched using propensity scores in a 1:1 ratio. The balance of each covar-
iate was assessed to ensure the model had been adequately specified. Cat-
egorical variables were compared using the chi-square test and continuous
variables using Student’s t test. Kaplan-Meier survival analysis with the
log-rank test after propensity matching was used for the long-term survival
estimates. The significance levels were set at an a of 0.05 in all cases. Sta-
tistical analysis was performed using R, version 2.15.1 (R Project for Sta-
tistical Computing, R Foundation, Vienna, Austria).RESULTS
The overall study population included 440 patients. ACP
was used in 360 procedures (81.8%) and RCP in 80
(18.2%). Before adjustment, significant age and gender dif-
ferences between the 2 groups were noted. Additionally, the
prematch ACP patients tended to have an increased comor-
bid disease burden, including more hypertension (82% vs
69%; P ¼ .01), tobacco abuse (49% vs 31%; P< .01),
chronic obstructive pulmonary disease (13% vs 5%;
P ¼ .03), and congestive heart failure (49% vs 31%;
P<.01; Table 1). The prematch ACP cohort (Table 2) also
included more nonelective operations (30% vs 11%;
P<.01), redo sternotomy (21% vs 5%; P<.01), and acute
or chronic dissection as the aortic pathologic entity (32% vs
11%; P<.01). The prematch ACP patients had also morediovascular Surgery c Volume 148, Number 6 2897
FIGURE 1. Histogram demonstrating number of antegrade cerebral
perfusion (ACP) and retrograde cerebral perfusion (RCP) hemiarch cases
annually. (The data for 2013 included only patients treated before the study
endpoint, February 2013).
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vs 29%; P ¼ .04) and had a larger average maximal aortic
diameter (5.7 cm vs 5.3 cm; P<.01).
Regarding the intraoperative variables (Table 3), before
matching, the patients receiving RCP were more likely to
have had intraoperative electroencephalographic moni-
toring (94% vs 79%; P< .01), consistent with a greaterTABLE 1. Patient demographics
Variable Overall (n ¼ 440) RCP (n ¼
Age (y) 57.1  13.9 50.9  13
Male gender 300 (68.2) 46 (57.5
White race 335 (76.1) 67 (83.4
Hypertension 35 (79.5) 55 (68.8
Hyperlipidemia 231 (52.5) 39 (48.9
Tobacco abuse history 202 (45.9) 25 (31.3
Diabetes 40 (9.1) 11 (13.8
CAD 102 (23.2) 17 (21.3
History of stroke or TIA 28 (6.4) 3 (3.4)
COPD 51 (11.6) 4 (5.0)
Baseline creatinine>1.5 mg/dL 46 (10.5) 6 (7.5)
PVD 21 (4.8) 3 (3.8)
Previous MI 29 (6.6) 4 (5.0)
CHF 150 (34.1) 39 (48.8
NYHA class IV 79 (18.0) 5 (6.3)
EF (%) 53.0  5.8 52.8  6
Genetically trigged aortic condition* 205 (46.6) 54 (67.5
Previous aortic surgery 83 (18.9) 5 (6.3)
Data presented as mean  standard deviation or n (%). RCP, Retrograde cerebral perfusi
ischemic attack; COPD, chronic obstructive pulmonary disease; PVD, peripheral vascu
York Heart Association; EF, ejection fraction. *Included patients with bicuspid aortopath
2898 The Journal of Thoracic and Cardiovascular Surpercentage of elective operations in the RCP group.
Although the crossclamp times did not differ between the
unadjusted groups, the RCP patients had shorter CPB times
before matching (198 vs 216 minutes; P<.01). The average
minimum nasopharyngeal temperature did not differ be-
tween the unadjusted groups. A trend was seen toward a
longer total DHCA time in the ACP group before matching
(19.1 vs 17.9 minutes; P ¼ .06), with no difference in the
adjunctive cerebral perfusion times.
An unadjusted comparison of the outcomes (Table 4) did
not reveal any differences in the occurrence of any neurologic
complication (10.8% ACP vs 7.5% RCP; P¼ .36), 30-day/
in-hospital mortality (3.6%ACP vs 2.5% RCP; P¼ .61), or
composite 30-day/in-hospital major morbidity (17.5% ACP
vs15.0%RCP;P¼ .59). Themeanoperative timewas nearly
50minutes longer in the ACP group (353.4 vs 308.3minutes;
P<.01), and the intraoperative use of factor VIIa was more
predominant in the ACP group before matching.16
More specifically, regarding the primary study endpoint
of any neurologic complication (TND, transient ischemic
attack, or clinical stroke), approximately 10% of patients
(n ¼ 45) in the entire cohort experienced 1 neurologic
complication. Of these, the vast majority (n ¼ 36) were
TND, defined as any postoperative transient mental status
change, including delirium or disorientation. Three patients
experienced a transient ischemic attack, defined as a new
neurologic deficit that had resolved completely within 24
hours. Finally, 13 patients (3.0%) had clinical strokes,
most of which presented as new motor deficits persisting
for >24 hours. Of the 13 patients, 10 had imaging80)
Before matching After matching
ACP (n ¼ 360) P value ACP (n ¼ 80) P value
.7 58.4  13.7 <.01 50.7  14.2 .46
) 254 (70.6) .03 50 (62.5) .52
) 268 (74.4) .07 66 (82.5) .83
) 295 (81.9) .01 60 (75.0) .38
) 192 (53.3) .46 39 (48.8) .99
) 177 (49.2) <.01 30 (37.5) .41
) 29 (8.1) .13 5 (6.3) .11
) 85 (23.6) .65 16 (20.0) .85
25 (6.9) .26 1 (1.3) .31
47 (13.1) .03 10 (12.5) .09
40 (11.1) .32 6 (7.5) .99
18 (5.0) .63 2 (2.5) .65
25 (6.9) .51 2 (2.5) .41
) 111 (30.8) <.01 36 (45.0) .63
74 (20.6) <.01 7 (8.8) .94
.2 53.0  5.8 .77 52.6  6.7 .83
) 151 (41.9) <.01 53 (66.3) .87
78 (21.7) <.01 7 (8.8) .55
on; ACP, antegrade cerebral perfusion; CAD, coronary artery disease; TIA, transient
lar disease; MI, myocardial infarction; CHF, congestive heart failure; NYHA, New
y or connective tissue disorder.
gery c December 2014
TABLE 2. Procedural characteristics
Variable Overall (n ¼ 440) RCP (n ¼ 80)
Before matching After matching
ACP (n ¼ 360) P value ACP (n ¼ 80) P value
Indication <.01 .99
Aneurysm 315 (71.6) 71 (88.8) 244 (67.8) 70 (87.5)
Acute dissection 91 (20.7) 6 (7.5) 85 (23.6) 6 (7.5)
Chronic dissection 34 (7.7) 3 (3.8) 31 (8.6) 4 (5.0)
Maximal aortic diameter (cm) 5.6  1.0 5.3  0.7 5.7  1.0 <.01 5.5  0.9 .46
Rupture 28 (6.4) 0 (0.0) 28 (7.8) <.01 0 (0.0) .99
Nonelective procedure status 116 (26.4) 9 (11.3) 107 (29.7) <.01 11 (13.8) .50
Redo sternotomy 80 (18.2) 4 (5.0) 76 (21.1) <.01 6 (7.5) .51
Procedure performed .04 .86
Root replacement and hemiarch 166 (37.7) 23 (28.8) 143 (39.8) 24 (30.0)
Ascending aortic replacement ( AVR) and hemiarch 274 (62.3) 57 (72.2) 217 (60.3) 56 (70.0)
Concomitant CABG 77 (17.5) 13 (16.3) 64 (17.8) .74 12 (15.0) .83
Concomitant valve repair or replacement 30 (6.8) 8 (10.0) 22 (6.1) .24 6 (7.5) .58
ASA class 4 132 (30.0) 9 (11.3) 123 (34.2) <.01 10 (12.5) .96
Data presented as mean  standard deviation or n (%). RCP, Retrograde cerebral perfusion; ACP, antegrade cerebral perfusion; AVR, aortic valve replacement; CABG, coronary
artery bypass grafting; ASA, American Society of Anesthesiologists.
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Dconfirmation with either computed tomography or magnetic
resonance imaging. In 4 of the 13 cases (31%) of clinical
stroke, the strokes were massive and resulted in death.
After 1:1 propensity matching, the RCP and ACP groups
did not demonstrate any significant differences in patient de-
mographics, procedural characteristics, or intraoperative
variables (Tables 1 to 3). Regarding the primary study
endpoint (Table 4), the incidence of any neurologic compli-
cation was similar between the 2 matched groups (11.3%
ACP vs 7.5% RCP; P ¼ .42). Furthermore, no significant
differences were found in any 30-day/in-hospital outcomes
(Table 4). The only significant difference that persisted be-
tween the 2 groups after matching was a shorter mean oper-
ative time in the RCP cohort, with RCP operations, on
average, 30 minutes shorter (308.3 vs 338.3 minutes;
P¼ .01). This differencewas likely attributable to the avoid-
ance of axillary cannulation and a greater use of central
aortic cannulation in the RCP group. Kaplan-Meier analysis
using only the matched patients did not reveal any signifi-
cant differences in overall long-term survival (P ¼ .90;
Figure 2), which was confirmed by the last clinical follow-
up examination and Social Security Death Index search.TABLE 3. Intraoperative variables
Variable Overall (n ¼ 440) RCP (n ¼ 80)
EEG monitoring 358 (81.4) 75 (93.8)
Crossclamp time (min) 136.3  39.9 131.0  44.2
CPB time (min) 212.9  48.7 197.9  40.8
Minimum NP temperature (C) 14.4  1.8 14.5  1.8
Circulatory arrest time (min) 18.9  6.5 17.9  4.3
RCP time (min) — 15.5  4.2
ACP time (min) — NA
Data presented as mean  standard deviation or n (%). RCP, Retrograde cerebral perfusi
pulmonary bypass; NP, nasopharyngeal; NA, not applicable.
The Journal of Thoracic and CarDISCUSSION
Neuroprotection in aortic arch surgery is an important
consideration given the mandatory period of cerebral
ischemia required for repair. Although multiple strategies
exist to minimize neurologic morbidity, comparative evi-
dence regarding the optimal method of neuroprotection is
lacking.9 The present study compared ACP and RCP in
the setting of DHCA and demonstrated that an equivalent
and acceptable safety profile can be achieved with either
adjunctive perfusion technique during elective or nonelec-
tive aortic hemiarch surgery. Specifically, the incidence of
major adverse neurologic events was low with either perfu-
sion strategy.
Given the importance of neuroprotection, recent pub-
lished data have called for a consensus regarding cerebral
protection during aortic arch surgery, specifically pertaining
to the optimal adjunctive cerebral perfusion strategy and pa-
tient temperature.10,17 Although a large body of published
data has described the outcomes of arch surgery using
either ACP or RCP, these studies have failed to provide
strong data regarding the comparative effectiveness of
each strategy.5,18-25 As highlighted in a recent publicationBefore matching After matching
ACP (n ¼ 360) P value ACP (n ¼ 80) P value
283 (78.6) <.01 72 (90.0) .39
137.4  38.8 .23 129.2  34.4 .78
216.2  49.7 <.01 208  59.8 .22
14.3  1.8 .56 14.2  1.8 .34
19.1  6.9 .06 17.7  6.4 .76
NA — NA —
15.0  5.8 — 14.2  5.1 —
on; ACP, antegrade cerebral perfusion; EEG, electroencephalographic; CPB, cardio-
diovascular Surgery c Volume 148, Number 6 2899
TABLE 4. Thirty-day/in-hospital outcomes
Variable Overall (n ¼ 440) RCP (n ¼ 80)
Before matching After matching
ACP (n ¼ 360) P value ACP (n ¼ 80) P value
Operative time (min) 345.2  76.5 308.3  72.7 353.4  74.9 <.01 338.3  80.3 .01
Any neurologic complication* 45 (10.3) 6 (7.5) 39 (10.8) .36 9 (11.3) .42
30-d/In-hospital mortality 15 (3.4) 2 (2.5) 13 (3.6) .61 3 (3.8) .65
30-d/In-hospital major composite morbidity 75 (17.0) 12 (15.0) 52 (17.5) .59 8 (10.0) .34
Any reoperation 19 (4.3) 2 (2.5) 17 (4.7) .35 2 (2.5) .99
Reoperation for bleeding 11 (2.5) 1 (1.3) 10 (2.8) .39 2 (2.5) .56
Intraoperative factor VIIa use 105 (23.9) 10 (12.5) 95 (26.4) <.01 14 (17.5) .38
Postoperative factor VIIa use 15 (3.4) 5 (6.3) 10 (2.8) .15 3 (3.8) .47
Prolonged (>24 h) ventilation 47 (10.7) 6 (7.5) 41 (11.4) .29 7 (8.8) .77
Acute renal failurey 35 (8.0) 8 (10.0) 27 (7.5) .47 4 (5.0) .23
New onset dialysis 9 (2.0) 2 (2.5) 7 (1.9) .76 3 (3.8) .65
TND 36 (8.2) 6 (7.5) 30 (8.3) .24 5 (6.3) .75
Clinical stroke 13 (3.0) 1 (1.3) 12 (3.3) .27 2 (2.5) .56
TIA 3 (0.7) 0 (0.0) 3 (0.8) .27 3 (3.8) .08
30-d Readmission 48 (10.9) 7 (8.8) 41 (11.4) .48 13 (16.3) .15
Discharge to other than home 28 (6.4) 3 (3.8) 25 (6.9) .26 2 (2.5) .65
Postoperative LOS (d) 7.7  7.2 6.9  5.5 7.9  7.5 .15 7.6  9.8 .58
Data presented as mean  standard deviation or n (%). RCP, Retrograde cerebral perfusion; ACP, antegrade cerebral perfusion; TND, transient neurologic dysfunction;
TIA, transient ischemic attack; LOS, length of stay. *Postoperative transient or permanent mental status change, TIA, or clinical stroke. yMaximum creatinine 2 times the baseline
creatinine and>2.0 g/dL.
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the current arch surgery data consist mainly of
observational studies without adequate control groups.9
The present report attempted to begin addressing this
knowledge gap by directly comparing ACP to RCP in a uni-
form population and with a propensity-matched control
group using matching for 40 pre- and intraoperative vari-
ables. The results we have presented demonstrate that for
hemiarch surgery in the setting of DHCA, RCP offers
neurologic, perioperative, and long-term outcomes equiva-
lent to those with ACP.FIGURE 2. Kaplan-Meier curves comparing long-term survival of pa-
tients undergoing antegrade (ACP) versus retrograde cerebral perfusion
(RCP).
2900 The Journal of Thoracic and Cardiovascular SurWe intentionally limited the study population to a
more uniform group that included only hemiarch proce-
dures, for which clinical equipoise regarding optimal
adjunctive cerebral perfusion strategy clearly exists,17
because total arch procedures have been demonstrated
to be an independent risk factor for adverse outcomes.1
Specifically, literature including total arch procedures in-
troduces additional complexity of analysis since these
procedures require longer periods of circulatory arrest,
which is another risk factor for PND.26,27 Notably, the
current study continues to demonstrate that excellent
outcomes can be obtained utilizing DHCA for proximal
arch replacement with one of the lowest incidences of
neurologic dysfunction in the literature, an overall
clinical stroke rate of 3%, including 1.9% in elective
cases.
Although permanent neurologic dysfunction has been the
standard used to describe adverse neurologic events, the po-
tential exists for subclinical neurologic events.12,28
Although the present study did not try to identify
subclinical neurologic deficits, outcomes such as discharge
to a destination other than home and the length of stay
(LOS) might provide surrogates for subtle neurologic
deficits, because patients with subclinical deficits might
not be able to care for themselves, necessitating a longer
LOS or institutional discharge. However, after propensity
matching, no difference in discharge to a destination other
than home or in the postoperative LOS was noted.
Additionally, the occurrence of discharge to a facility was
relatively low, 6.4% overall and 3.8% and 2.5% in the
RCP and ACP groups, respectively, after matching.gery c December 2014
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averaging just>7 days for all patients.
Study Limitations
The present study had some notable limitations. It was a
single-institution, retrospective analysis with an associated
inherent bias. Although we used a propensity-matched anal-
ysis to minimize treatment level biases, it could not adjust
for all potential unknown bias. Our study was also notable
because, before matching, no differences were found in
the unadjusted postoperative outcomes, although the ACP
patients were generally more ill. Thus, the comparisons
that included only the matched patients, which represented
a healthier patient population, might have underestimated
the true risk of neurologic morbidity, particularly in older
or sicker patients. Furthermore, the mean age of 51 years
in the matched cohorts was somewhat younger than in pre-
vious reports of proximal aortic replacement,1 likely owing
to a relatively large number of patients with bicuspid valve
aortopathy or connective tissue disorder (107 of 160 total
matched patients; 67%) in the matched cohort. As such,
the results might not be entirely generalizable to older
patients with degenerative aortic aneurysms. Moreover,
all operations were performed in the setting of a dedicated,
high-volume, multidisciplinary aortic center; thus, the pre-
sented results might not be applicable to centers without
these resources. The use of DHCA in all patients and the in-
clusion of only hemiarch procedures must also be acknowl-
edged; thus, our results will not be applicable to moderate
hypothermic circulatory arrest or total arch procedures,
which necessitate longer circulatory arrest times. In addi-
tion, all cases used adjunctive cerebral perfusion; thus, no
conclusions about the comparative effectiveness of DHCA
alone can be made, although a recent meta-analysis sug-
gested straight DHCAwas associated with a greater stroke
rate.29 Furthermore, our patients did not undergo a formal
neurologic examination postoperatively by trained neurolo-
gists; thus, the potential for underestimation of subtle
neurologic findings was present. Finally, the results of our
study could not address the larger question of the optimal
temperature for hypothermic circulatory arrest during aortic
arch surgery. That will require larger studies such as those
proposed by the International Aortic Arch Surgery Study
Group9 to fully investigate this challenging question.
CONCLUSIONS
Aortic arch surgery presents a unique neurologic risk
given the mandatory period of cerebral ischemia during sur-
gery. We have demonstrated that with DHCA, equivalent
outcomes can be achieved using either ACP or RCP in
both the elective and nonelective setting. The decreased
operative time with RCP might be advantageous from a
cost perspective and provide potential benefit by minimiza-
tion of the time in the operating room. Finally, although notThe Journal of Thoracic and Carthe focus of our study, more evidence regarding the optimal
temperature during arch replacement is essential for addi-
tional improvements in this challenging field of surgery.References
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Surg. 2013;2:148-58.MMENTARYBrain protection in aortic arch surgery: Antegrade cerebral
perfusion and retrograde cerebral perfusion need a tougher
row to hoeJohn A. Elefteriades, MD,a and Bulat A. Ziganshin, MDa,bThe article in this issue of the Journal of Thoracic and
Cardiovascular Surgery by Ganapathi and colleagues1
compares outcomes of aortic hemiarch replacement with
antegrade cerebral perfusion (ACP) versus retrograde cere-
bral perfusion (RCP) in a large number of patients. Ganapa-
thi and colleagues1 are to be congratulated for their superb
clinical results and well-written study. They have contrib-
uted significantly to our body of knowledge with this work.
Important design characteristics of this study include the
following:
 The 2 patient groups were very dissimilar initially, so pro-
pensitymatching was applied to overcome this limitation. The operations were all hemiarch procedures, so the cir-
culatory arrest times were all very short (generally less
than 20 minutes).
 The study included both elective and emergency cases.
 The patients were quite young (mean age, 51 years).
 The ACP and RCP groups were cooled to an unusually
low level (<15C).
This study provides useful data, solidifying the conven-
tional wisdom that operations requiring less than 30 mi-
nutes of deep hypothermic circulatory arrest (DHCA) are
safe regardless of modality of cerebral protection. In view
of this point, this study is unlikely to change practice but
rather affirms current principles.
The restriction to hemiarch operations is both a benefit
and a liability. This restriction makes for an important
element of uniformity among patients but at the same
time limits the degree to which the findings can be
generalized.
It is important to note that Ganapathi and colleagues1
delivered ACP only to one side of the brain through a right
axillary cannula only. This is highly controversial because
of the concern that ACP blood may not adequately reach re-
gions remote from the right carotid artery, especially in case
of an incomplete circle of Willis. Many experts advocate
perfusion of both carotids, or even of both carotids and
the left subclavian artery (to recruit the left vertebral artery
as well).2gery c December 2014
